Aurobindo Pharma Ltd
NSE :AUROPHARMA BSE :524804 Sector : PharmaceuticalsBuy, Sell or Hold AUROPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
22 Apr 1187.70 (-1.12%) | 21 Apr 1201.20 (2.53%) | 17 Apr 1171.60 (3.37%) | 16 Apr 1133.40 (-0.11%) | 15 Apr 1134.70 (4.83%) | 11 Apr 1082.45 (2.31%) | 09 Apr 1058.00 (-3.56%) | 08 Apr 1097.00 (0.27%) | 07 Apr 1094.05 (-1.02%) | 04 Apr 1105.35 (-6.04%) | 03 Apr 1176.35 (1.60%) | 02 Apr 1157.85 (2.09%) | 01 Apr 1134.15 (-2.27%) | 28 Mar 1160.50 (-0.32%) | 27 Mar 1164.25 (0.59%) | 26 Mar 1157.45 (-3.14%) | 25 Mar 1194.95 (-1.21%) | 24 Mar 1209.60 (0.77%) | 21 Mar 1200.35 (2.23%) | 20 Mar 1174.15 (0.89%) | 19 Mar 1163.80 (2.36%) |
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Bearish
Moving Averages
5 DMA
Bullish
1165.71
10 DMA
Bullish
1126.43
20 DMA
Bullish
1149.79
50 DMA
Bullish
1135.27
100 DMA
Bullish
1183
200 DMA
Bearish
1307.54
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Apr 22, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1240.14 | 1227.77 | 1196.61 | - | - |
R2 | 1227.77 | 1215.39 | 1193.64 | 1225.85 | - |
R1 | 1207.74 | 1207.75 | 1190.67 | 1203.9 | 1217.75 |
P | 1195.37 | 1195.37 | 1195.37 | 1193.45 | 1200.38 |
S1 | 1175.34 | 1182.99 | 1184.73 | 1171.5 | 1185.35 |
S2 | 1162.97 | 1175.35 | 1181.76 | 1161.05 | - |
S3 | 1142.94 | 1162.97 | 1178.79 | - | - |
Key Metrics
EPS
32.72
P/E
36.31
P/B
3.54
Dividend Yield
0.38%
Market Cap
69,592 Cr.
Face Value
1
Book Value
335.47
ROE
11.18%
EBITDA Growth
1,735.86 Cr.
Debt/Equity
0.21
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Aurobindo Pharma Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 7514.3 | 7715.77 | 7787.95 | 7932.37 | 8137.4 | |
PROFIT | 936.29 | 974.2 | 919.22 | 817.38 | 845.81 | |
EPS | 16.04 | 15.51 | 15.69 | 14 | 14.56 |
Aurobindo Pharma Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 3023.3 | 3017 | 2525.41 | 2947.25 | 2970.89 | |
PROFIT | 623.77 | 578.67 | 329.04 | 537.53 | 472.05 | |
EPS | 10.65 | 9.88 | 5.62 | 9.21 | 8.13 |
Profit & Loss (Figures in Rs. Crores)
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 12546.71 | 14092.78 | 15339.65 | 17050.67 | 20397.12 | 23392.24 | 29135.18 | 23075.19 | 25555.65 | 30505.42 | |
PROFIT | 1587.14 | 2028.78 | 2306.24 | 2423.17 | 2430.63 | 2864.68 | 3410.14 | 2757.17 | 1919.7 | 3272.95 | |
EPS | 26.48 | 34.58 | 38.88 | 41.35 | 40.36 | 48.54 | 91.04 | 45.18 | 32.9 | 54.09 |
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8321.41 | 9496.13 | 9711.68 | 10684.73 | 12746.91 | 13998.23 | 16410.55 | 11912.62 | 9164.87 | 11431.97 | |
PROFIT | 1518.29 | 1627.51 | 1720.3 | 1812.82 | 1537.74 | 1878.78 | 3113.04 | 1535.98 | 1217.17 | 1952.97 | |
EPS | 25.54 | 27.8 | 28.73 | 30.94 | 26.11 | 32.03 | 53.13 | 24.83 | 20.94 | 33.35 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 29,784.21 | 26,781.26 | 24,517.39 | 21,871.28 | 16,766.08 | 13,832.19 | 11,621.83 | 9,313.32 | 7,228.78 | 5,126.71 |
Total Shareholders Funds | 29,842.8 | 26,839.85 | 24,575.98 | 21,929.87 | 16,824.67 | 13,890.78 | 11,680.42 | 9,371.91 | 7,287.3 | 5,155.91 |
Minority Interest | 8 | 12 | -1.93 | -0.88 | 0.14 | 1.59 | 1.82 | 2.08 | 2.55 | 25.82 |
Secured Loans | 3,968.37 | 2,557.37 | 543.69 | 1,053.55 | 1,314.97 | 1,661.87 | 419.18 | 640.8 | 2,285.15 | 2,081.94 |
Unsecured Loans | 2,679.26 | 2,728.84 | 2,307.58 | 4,285.53 | 4,511.41 | 5,304.89 | 4,350.75 | 2,723.34 | 2,755.92 | 2,369.13 |
Total Debt | 6,647.63 | 5,286.21 | 2,851.27 | 5,339.08 | 5,826.38 | 6,966.76 | 4,769.93 | 3,364.14 | 5,041.07 | 4,451.07 |
Other Liabilities | 277.59 | 214.26 | 212.91 | 250.71 | 162.19 | 80.16 | 66.43 | 39.13 | 23.36 | 24.35 |
Total Liabilities | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 23,447.77 | 18,593.32 | 15,524.55 | 13,613.33 | 12,441.26 | 10,497.62 | 7,894.78 | 5,635.49 | 4,569.83 | 5,446.13 |
Less: Accumulated Depreciation | 8,954.98 | 7,569.63 | 4,992.46 | 4,239.75 | 3,044.79 | 2,022.77 | 1,374.1 | 801.71 | 390.14 | 1,740.49 |
Net Block | 14,492.79 | 11,023.69 | 10,532.09 | 9,373.58 | 9,396.47 | 8,474.85 | 6,520.68 | 4,833.78 | 4,179.69 | 3,705.64 |
Capital Work in Progress | 3,868.72 | 5,390.01 | 3,747.2 | 3,061.53 | 1,985.92 | 1,668.46 | 1,583.04 | 1,458.08 | 848.14 | 419.63 |
Investments | 372.23 | 542.74 | 997.15 | 591.01 | 554.71 | 360.22 | 311.54 | 245.87 | 122.96 | 19.79 |
Inventories | 9,810.47 | 8,516.11 | 7,559.08 | 9,041.18 | 7,699.87 | 7,245.6 | 5,858.41 | 4,330.54 | 4,056.14 | 3,611.3 |
Sundry Debtors | 4,816.74 | 4,466.38 | 4,012.26 | 3,503.28 | 4,315.16 | 3,413.78 | 3,080.2 | 2,765.33 | 4,606.68 | 3,539.17 |
Cash and Bank Balance | 6,278.3 | 6,084.2 | 4,190.01 | 5,474.28 | 2,842.15 | 1,957.18 | 1,262.25 | 513.48 | 800.26 | 469.11 |
Loans and Advances | 2,818.07 | 2,247.1 | 1,987.72 | 1,659.59 | 1,555.31 | 2,715.72 | 1,977.28 | 1,596.81 | 831.25 | 659.57 |
Total Current Assets | 23,723.58 | 21,313.79 | 17,749.07 | 19,678.33 | 16,412.49 | 15,332.28 | 12,178.14 | 9,206.16 | 10,294.33 | 8,279.15 |
Current Liabilities | 7,433.13 | 6,735.93 | 5,643.94 | 5,378.37 | 5,310.95 | 4,849.09 | 4,052.93 | 3,161.5 | 3,409.03 | 2,828.56 |
Provisions | 508.04 | 417.01 | 233.82 | 396.89 | 511.72 | 384.67 | 294.23 | 261.36 | 132.93 | 218.24 |
Total Current Liabilities & Provisions | 7,941.17 | 7,152.94 | 5,877.76 | 5,775.26 | 5,822.67 | 5,233.76 | 4,347.16 | 3,422.86 | 3,541.96 | 3,046.8 |
Net Current Assets | 15,782.41 | 14,160.85 | 11,871.31 | 13,903.07 | 10,589.82 | 10,098.52 | 7,830.98 | 5,783.3 | 6,752.37 | 5,232.35 |
Deferred Tax Assets | 1,335.71 | 768.88 | 429.74 | 600.91 | 163.2 | 183.29 | 539.17 | 501.82 | 227.37 | 33.3 |
Deferred Tax Liability | 479.63 | 481 | 552.11 | 722.79 | 291.69 | 281.31 | 615.65 | 383.36 | 45.05 | 239.08 |
Net Deferred Tax | 856.08 | 287.88 | -122.37 | -121.88 | -128.49 | -98.02 | -76.48 | 118.46 | 182.32 | -205.78 |
Other Assets | 1,403.79 | 947.15 | 612.85 | 711.47 | 414.95 | 435.26 | 348.84 | 337.77 | 268.8 | 485.52 |
Total Assets | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
Contingent Liabilities | 311.34 | 158.53 | 157.74 | 140.83 | 145.98 | 133.71 | 211.79 | 196.97 | 177.11 | 195.38 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 19,664.23 | 17,975.44 | 17,058.75 | 15,866.02 | 12,993.91 | 11,292.03 | 9,923.99 | 8,377.59 | 6,807.33 | 5,330.34 |
Total Shareholders Funds | 19,722.82 | 18,034.03 | 17,117.34 | 15,924.61 | 13,052.5 | 11,350.62 | 9,982.58 | 8,436.18 | 6,865.85 | 5,359.54 |
Secured Loans | 1,431.99 | 1,922.78 | 288.75 | 841.5 | 1,314.36 | 1,594.43 | 376.19 | 498.65 | 1,002.71 | 1,884.01 |
Unsecured Loans | 1,428.75 | 2,280.38 | 1,606.14 | 3,200.46 | 2,427.1 | 2,925.37 | 3,342.81 | 2,555.26 | 3,162.72 | 1,400.72 |
Total Debt | 2,860.74 | 4,203.16 | 1,894.89 | 4,041.96 | 3,741.46 | 4,519.8 | 3,719 | 3,053.91 | 4,165.43 | 3,284.73 |
Other Liabilities | 46 | 87.31 | 5.03 | 0 | 42.68 | 22.64 | 33.6 | 20.87 | 21.26 | 22.65 |
Total Liabilities | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,043.49 | 6,214.71 | 5,724.9 | 6,688.9 | 6,180.91 | 5,446.15 | 4,292.18 | 3,758.18 | 2,830.78 | 3,507.54 |
Less : Accumulated Depreciation | 1,624.36 | 2,527.21 | 2,139.07 | 2,216.83 | 1,763.11 | 1,296.45 | 899.21 | 546.56 | 262.65 | 1,317.53 |
Net Block | 2,419.13 | 3,687.5 | 3,585.83 | 4,472.07 | 4,417.8 | 4,149.7 | 3,392.97 | 3,211.62 | 2,568.13 | 2,190.01 |
Capital Work in Progress | 132.68 | 239.09 | 225.15 | 734.89 | 814.85 | 789.01 | 1,143.98 | 906.98 | 742.14 | 227.19 |
Investments | 13,393.44 | 8,105.37 | 6,584.36 | 5,009.93 | 2,527.41 | 2,339.06 | 1,967.5 | 1,681.95 | 1,183.35 | 1,012.75 |
Inventories | 2,367.6 | 4,125.26 | 3,356.18 | 4,841.38 | 4,359.57 | 3,971.26 | 3,409.23 | 2,433.62 | 2,431.6 | 2,145.05 |
Sundry Debtors | 3,776.59 | 4,560.26 | 3,973.24 | 5,928.01 | 5,785 | 5,232.07 | 4,468.23 | 3,773.63 | 4,380.97 | 3,708.94 |
Cash and Bank Balance | 94.34 | 373.41 | 50.78 | 386.18 | 86.16 | 75.77 | 245.9 | 33.64 | 330.81 | 11.13 |
Loans and Advances | 1,000.59 | 906.05 | 2,454.9 | 1,051.4 | 1,057.55 | 1,129.22 | 857.82 | 662.44 | 631.1 | 483.32 |
Total Current Assets | 7,239.12 | 9,964.98 | 9,835.1 | 12,206.97 | 11,288.28 | 10,408.32 | 8,981.18 | 6,903.33 | 7,774.48 | 6,348.44 |
Current Liabilities | 2,285.86 | 2,396.31 | 2,243.3 | 2,539.03 | 2,526.66 | 2,120.15 | 1,960.64 | 1,450.46 | 1,456.07 | 1,262.6 |
Provisions | 119.65 | 122.09 | 103.36 | 250.01 | 115.27 | 96.51 | 74.54 | 61.5 | 56.95 | 86.02 |
Total Current Liabilities & Provisions | 2,405.51 | 2,518.4 | 2,346.66 | 2,789.04 | 2,641.93 | 2,216.66 | 2,035.18 | 1,511.96 | 1,513.02 | 1,348.62 |
Net Current Assets | 4,833.61 | 7,446.58 | 7,488.44 | 9,417.93 | 8,646.35 | 8,191.66 | 6,946 | 5,391.37 | 6,261.46 | 4,999.82 |
Deferred Tax Assets | 47.45 | 55.24 | 43.82 | 68.61 | 411.92 | 439.87 | 382.06 | 333.52 | 267.97 | 28.55 |
Deferred Tax Liability | 166.36 | 271.15 | 280.85 | 501.99 | 496.96 | 470.87 | 405.54 | 333.44 | 261.11 | 238.89 |
Net Deferred Tax | -118.91 | -215.91 | -237.03 | -433.38 | -85.04 | -31 | -23.48 | 0.08 | 6.86 | -210.34 |
Other Assets | 1,969.61 | 3,061.87 | 1,370.51 | 765.13 | 515.27 | 454.63 | 308.21 | 318.96 | 290.6 | 447.49 |
Total Assets | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
Contingent Liabilities | 1,969.15 | 534.26 | 152.93 | 770.1 | 2,006.56 | 2,496.37 | 1,214.54 | 427.41 | 799.8 | 558.92 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,379.99 |
Depreciation | 1,521.66 |
Interest (Net) | -17.67 |
P/L on Sales of Assets | -23.49 |
P/L on Sales of Invest | -0.1 |
Prov. and W/O (Net) | 52.53 |
P/L in Forex | -51.14 |
Total Adjustments (PBT and Ext... | 1,496.24 |
Operating Profit before Workin... | 5,876.23 |
Trade and 0ther Receivables | -264.19 |
Inventories | -1,303.68 |
Trade Payables | 582.84 |
Loans and Advances | -0.69 |
Total Adjustments (OP before W... | -1,675.07 |
Cash Generated from/(used in) ... | 4,201.16 |
Direct Taxes Paid | -1,766.64 |
Total Adjustments(Cash Generat... | -1,766.64 |
Cash Flow before Extraordinary... | 2,434.52 |
Net Cash from Operating Activi... | 2,434.52 |
Purchased of Fixed Assets | -3,561.5 |
Sale of Fixed Assets | 60.28 |
Purchase of Investments | -25.7 |
Sale of Investments | 179.15 |
Interest Received | 280.84 |
Net Cash used in Investing Act... | -4,241.78 |
Proceed from 0ther Long Term B... | 1,563.24 |
Of the Long Tem Borrowings | -17.17 |
Of the Short Term Borrowings | -84.76 |
Of Financial Liabilities | -146.6 |
Dividend Paid | -263.64 |
Interest Paid | -250.65 |
Net Cash used in Financing Act... | 800.42 |
Net Profit before Tax and Extr... | 2,475.41 |
Depreciation | 348.66 |
Interest (Net) | -15.89 |
Dividend Received | 264.67 |
P/L on Sales of Assets | -1.43 |
P/L on Sales of Invest | 30.07 |
Prov. and W/O (Net) | 11.11 |
P/L in Forex | -38.11 |
Total Adjustments (PBT and Ext... | 69.61 |
Operating Profit before Workin... | 2,545.02 |
Trade and 0ther Receivables | -743.59 |
Inventories | -308.34 |
Trade Payables | 751.9 |
Loans and Advances | -1.11 |
Total Adjustments (OP before W... | -228.04 |
Cash Generated from/(used in) ... | 2,316.98 |
Direct Taxes Paid | -602.18 |
Total Adjustments(Cash Generat... | -602.18 |
Cash Flow before Extraordinary... | 1,714.8 |
Net Cash from Operating Activi... | 1,714.8 |
Purchased of Fixed Assets | -426.75 |
Sale of Fixed Assets | 4.68 |
Purchase of Investments | -3,932.05 |
Sale of Investments | 11.92 |
Interest Received | 199.51 |
Loans to Subsidiaires | -2,345.35 |
Net Cash used in Investing Act... | -151.58 |
Of the Short Term Borrowings | -1,341.96 |
Of Financial Liabilities | -21.71 |
Dividend Paid | -263.64 |
Interest Paid | -209.72 |
Net Cash used in Financing Act... | -1,837.03 |
Company Details
Registered Office |
|
Address | Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Registrars |
|
Address | Plot No 2 Maitrivihar |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Management |
|
Name | Designation |
Kambam Nityananda Reddy | Vice Chairman & M.D. |
M Madan Mohan Reddy | Whole-time Director |
P V Ramprasad Reddy | Non Executive Director |
Savita Mahajan | Independent Director |
Girish Paman Vanvari | Independent Director |
P Sarath Chandra Reddy | Non Executive Director |
Santanu Mukherjee | Independent Director |
Deepali Pant Joshi | Independent Director |
M R Kumar | Chairman & Independent Directo |
Satakarni Makkapati | Non Executive Director |